- Home
- BODI vs MRSN Comparison
BODI vs MRSN Comparison
Compare BODI & MRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BODI
- MRSN
- Stock Information
- Founded
- BODI 1998
- MRSN 2001
- Country
- BODI United States
- MRSN United States
- Employees
- BODI N/A
- MRSN N/A
- Industry
- BODI Industrial Machinery/Components
- MRSN Biotechnology: Pharmaceutical Preparations
- Sector
- BODI Industrials
- MRSN Health Care
- Exchange
- BODI Nasdaq
- MRSN Nasdaq
- Market Cap
- BODI 31.6M
- MRSN 37.0M
- IPO Year
- BODI N/A
- MRSN 2017
- Fundamental
- Price
- BODI $5.35
- MRSN $7.75
- Analyst Decision
- BODI Buy
- MRSN Strong Buy
- Analyst Count
- BODI 2
- MRSN 4
- Target Price
- BODI $10.00
- MRSN $63.67
- AVG Volume (30 Days)
- BODI 26.0K
- MRSN 123.1K
- Earning Date
- BODI 08-05-2025
- MRSN 08-13-2025
- Dividend Yield
- BODI N/A
- MRSN N/A
- EPS Growth
- BODI N/A
- MRSN N/A
- EPS
- BODI N/A
- MRSN N/A
- Revenue
- BODI $324,871,000.00
- MRSN $34,769,000.00
- Revenue This Year
- BODI N/A
- MRSN N/A
- Revenue Next Year
- BODI N/A
- MRSN $1.03
- P/E Ratio
- BODI N/A
- MRSN N/A
- Revenue Growth
- BODI N/A
- MRSN 16.14
- 52 Week Low
- BODI $3.38
- MRSN $5.21
- 52 Week High
- BODI $8.71
- MRSN $70.75
- Technical
- Relative Strength Index (RSI)
- BODI 62.34
- MRSN 53.41
- Support Level
- BODI $4.85
- MRSN $6.96
- Resistance Level
- BODI $5.97
- MRSN $7.68
- Average True Range (ATR)
- BODI 0.48
- MRSN 0.58
- MACD
- BODI 0.07
- MRSN 0.19
- Stochastic Oscillator
- BODI 71.95
- MRSN 85.14
About BODI The Beachbody Company Inc. Class A Common Stock
The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.